These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5770982)

  • 1. Effect of antibodies against skeletal muscle constituents on muscle function in rats.
    Namba T; Grob D
    Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
    Namba T
    Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.
    Namba T; Grob D
    Neurology; 1968 Mar; 18(3):273. PubMed ID: 5689669
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis as a receptor disorder.
    Drachman DB; Kao I; Pestronk A; Toyka KV
    Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
    [No Abstract]   [Full Text] [Related]  

  • 5. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of prostigmin on the basal electromyogram in myasthenia.
    Wochnik-Dyjas D; Niewiadomska M
    Pol Med J; 1970; 9(4):932-8. PubMed ID: 4320112
    [No Abstract]   [Full Text] [Related]  

  • 9. A new test for myasthenia gravis: recording of miniature end-plate potentials in situ.
    Lovelace RE; Stone R; Zablow L
    Neurology; 1970 Apr; 20(4):385. PubMed ID: 5535003
    [No Abstract]   [Full Text] [Related]  

  • 10. Some different aspects of post-tetanic phenomena in myasthenia gravis.
    Pinelli P; Arrigo A; Mille T
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):190. PubMed ID: 4166736
    [No Abstract]   [Full Text] [Related]  

  • 11. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reassessment of the neurophysiological evidence for a presynaptic defect in myasthenia gravis.
    Bergmans J; Fannes-Breselow CF; Gribomont B
    Electromyogr Clin Neurophysiol; 1976; 16(4):337-51. PubMed ID: 187402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myasthenia gravis symptoms in rabbits after development of antibodies against acetylcholine receptors].
    Heilbronn E; Hilton-Brown P; Mattsson C; Stålberg E
    Lakartidningen; 1975 Apr; 72(15):1558-60. PubMed ID: 1134154
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-tetanic fibrillary potentials in rat skeletal muscle. Site of origin.
    Llados F; Belmar J
    Acta Physiol Lat Am; 1973; 23(3):213-20. PubMed ID: 4271920
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission.
    Namba T; Grob D
    Neurology; 1969 Feb; 19(2):173-84. PubMed ID: 5812611
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle.
    Kuba K; Albuquerque EX; Daly J; Barnard EA
    J Pharmacol Exp Ther; 1974 May; 189(2):499-512. PubMed ID: 4545375
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of propranolol on the isolated phrenic nerve-diaphragm preparation of the rat.
    Paradelis AG; Theocharidis NC; Logaras G
    Arzneimittelforschung; 1973 Jan; 23(1):38-40. PubMed ID: 4353375
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of sensitivity to curare in myasthenic disorders using a regionaltechnique.
    Brown JC; Charlton JE
    J Neurol Neurosurg Psychiatry; 1975 Jan; 38(1):27-33. PubMed ID: 1117298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable effect of calcium channel blockers on the decremental response in experimental autoimmune myasthenia gravis.
    Wirguin I; Brenner T; Sicsic C; Argov Z
    Muscle Nerve; 1994 May; 17(5):523-7. PubMed ID: 8159183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.